• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MANUFACTURING INC LACTATE DEHYDROGENASE; LACTATE DEHYGROGENASE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MANUFACTURING INC LACTATE DEHYDROGENASE; LACTATE DEHYGROGENASE Back to Search Results
Catalog Number 02P56-21
Device Problem High Test Results (2457)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Type  malfunction  
Manufacturer Narrative
This event was previously reported in manufacturer report number 1415939-2017-00093.The manufacturer location was incorrectly documented.This report is being filed.Further investigation of the customer issue included a review of the complaint text, inhouse testing, instrument log review, a search for similar complaints, and a review of labeling.Returned material was available but not returned.The assay files were successfully calibrated and each validity control replicate generated was within the established ranges demonstrating the reagent lot is performing within specification.A review of the instrument logs confirmed that an error code was generated during the timeframe the customer generated the discrepant result.This error could indicate the presence of bubbles, foam, or fibrin in the sample.Tracking and trending did not identify an adverse trend.Labeling was reviewed and found to be adequate.Based on the available information no product deficiency of the clinical chemistry lactate dehydrogenase (ldh) assay,ln 02p56, lot number 47146un15, was identified.
 
Event Description
The customer observed falsely elevated lactate dehygrogenase (ldh) results while using the clinical chemistry ldh assay.The customer provided the following results: patient 1: (no sid provided) initial 121, retest 93 sid: (b)(6), initial 641, retest 279 and 315, sid: (b)(6), initial 1286, retest 279 and 219, sid: (b)(6), initial 636, retest 251 and 251.No impact to patient management was reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LACTATE DEHYDROGENASE
Type of Device
LACTATE DEHYGROGENASE
Manufacturer (Section D)
ABBOTT MANUFACTURING INC
1921 hurd drive
irving TX 75038
Manufacturer (Section G)
ABBOTT MANUFACTURING INC
1921 hurd drive
irving TX 75038
Manufacturer Contact
noemi romero-kondos, rn bsn
100 abbott park road
dept. 09b9, lccp1-3
abbott park, IL 60064-3537
224667-512
MDR Report Key8446018
MDR Text Key139706828
Report Number1628664-2019-00245
Device Sequence Number1
Product Code CFJ
UDI-Device Identifier00380740004033
UDI-Public00380740004033
Combination Product (y/n)N
Reporter Country CodeCA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 03/22/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/21/2016
Device Catalogue Number02P56-21
Device Lot Number47146UN15
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/22/2019
Initial Date FDA Received03/22/2019
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured11/01/2015
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
-
-